Variants in genes coding for collagen type IV α-chains are frequent causes of persistent, isolated hematuria during childhood

• Published in: Pediatric nephrology (Berlin, West) Vol. 38; no. 3; pp. 687 - 695
• Main Authors: Alge, Joseph L., Bekheirnia, Nasim, Willcockson, Alexandra R., Qin, Xiang, Scherer, Steven E., Braun, Michael C., Bekheirnia, Mir Reza
• Format: Journal Article
• Language: English
• Published: Berlin/Heidelberg Springer Berlin Heidelberg 01.03.2023; Springer Nature B.V
• Subjects: Autoantigens - genetics; Child; Children; Collagen; Collagen (type IV); Collagen Type IV - genetics; Genetic screening; Genetic testing; Genomics; Hematuria; Hematuria - diagnosis; Hematuria - genetics; Humans; Kidney - pathology; Kidney diseases; Medicine; Medicine & Public Health; Mutation; Nephritis, Hereditary - genetics; Nephrology; Next-generation sequencing; Original Article; Pediatrics; Pedigree; Population genetics; Urinalysis; Urology; Children; Hematuria; Type IV collagen; Alport syndrome
• ISSN: 0931-041X; 1432-198X
• DOI: 10.1007/s00467-022-05627-w

Background Children with persistent, isolated microscopic hematuria typically undergo a limited diagnostic workup and are monitored for signs of kidney disease in long-term longitudinal follow-up, which can delay diagnosis and allow disease progression in some cases. Methods To determine the clinical utility of genetic screening in this population, we performed targeted genetic testing using a custom, 32-gene next-generation sequencing panel for progressive kidney disease on children referred to the Texas Children’s Hospital Pediatric Nephrology clinic for persistent, microscopic hematuria ( n  = 30; cohort 1). Patients with microscopic hematuria identified by urinalysis on at least two separate occasions were eligible for enrollment, but those with other evidence of kidney disease were excluded. Results were analyzed for sequence variants using the American College of Medical Genetics and Genomics (ACMG) guideline for data interpretation and were validated using a secondary analysis of a dataset of children with hematuria and normal kidney function who had undergone genetic testing as part of an industry-sponsored program (cohort 2; n  = 67). Results In cohort 1 33% of subjects (10/30) had pathogenic or likely pathogenic (P/LP) variants in the type IV collagen genes ( COL4A3/A4/A5 ), and 10% (3/30) had variants of uncertain significance in these genes. The high diagnostic rate in type IV collagen genes was confirmed in cohort 2, where 27% (18/67) of subjects had P/LP variants in COL4A3/A4/A5 genes. Conclusions Children with persistent, isolated microscopic hematuria have a high likelihood of having pathogenic variants in type IV collagen genes and genetic screening should be considered. Graphical Abstract A higher resolution version of the Graphical abstract is available as Supplementary information